Abstract
Malignant hyperthermia susceptibility remains the commonest cause of death owing to general anaesthesia. This is despite the availability of presymptomatic testing, admittedly by a highly invasive method, and a recognised treatment for implementation immediately a patient shows signs of developing a crisis. Recently the finding of linkage to markers from chromosome 19q13.1-13.2 and the identification of mutations in a candidate gene held out hope of genetic diagnosis being available. However, it is likely that only about 50% of families have a mutation of the skeletal muscle calcium release channel gene. With this degree of genetic heterogeneity, presymptomatic testing based on DNA markers can only be offered at present to a limited number of families where linkage to markers from 19q13.1-13.2 has been clearly shown.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andresen E., Jensen P. Close linkage established between the HAL locus for halothane sensitivity and the PHI (phosphohexose isomerase) locus in pigs of the Danish Landrace breed. Nord Vet Med. 1977 Nov;29(11):502–504. [PubMed] [Google Scholar]
- Britt B. A., Kalow W. Malignant hyperthermia: a statistical review. Can Anaesth Soc J. 1970 Jul;17(4):293–315. doi: 10.1007/BF03004694. [DOI] [PubMed] [Google Scholar]
- Brownell A. K. Malignant hyperthermia: relationship to other diseases. Br J Anaesth. 1988 Feb;60(3):303–308. doi: 10.1093/bja/60.3.303. [DOI] [PubMed] [Google Scholar]
- Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C., de Jong P., Jansen G., Anvret M., Riley B. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 1992 Feb 6;355(6360):547–548. doi: 10.1038/355547a0. [DOI] [PubMed] [Google Scholar]
- Campbell K. P., Knudson C. M., Imagawa T., Leung A. T., Sutko J. L., Kahl S. D., Raab C. R., Madson L. Identification and characterization of the high affinity [3H]ryanodine receptor of the junctional sarcoplasmic reticulum Ca2+ release channel. J Biol Chem. 1987 May 15;262(14):6460–6463. [PubMed] [Google Scholar]
- DENBOROUGH M. A., FORSTER J. F., LOVELL R. R., MAPLESTONE P. A., VILLIERS J. D. Anaesthetic deaths in a family. Br J Anaesth. 1962 Jun;34:395–396. doi: 10.1093/bja/34.6.395. [DOI] [PubMed] [Google Scholar]
- Davies W., Harbitz I., Fries R., Stranzinger G., Hauge J. G. Porcine malignant hyperthermia carrier detection and chromosomal assignment using a linked probe. Anim Genet. 1988;19(3):203–212. doi: 10.1111/j.1365-2052.1988.tb00809.x. [DOI] [PubMed] [Google Scholar]
- Denborough M. A., Dennett X., Anderson R. M. Central-core disease and malignant hyperpyrexia. Br Med J. 1973 Feb 3;1(5848):272–273. doi: 10.1136/bmj.1.5848.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deufel T., Golla A., Iles D., Meindl A., Meitinger T., Schindelhauer D., DeVries A., Pongratz D., MacLennan D. H., Johnson K. J. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet. 1992 Jun;50(6):1151–1161. [PMC free article] [PubMed] [Google Scholar]
- Ellis F. R. Detecting susceptibility to malignant hyperthermia. BMJ. 1992 Mar 28;304(6830):791–792. doi: 10.1136/bmj.304.6830.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellis F. R., Halsall P. J., Harriman D. G. The work of the Leeds Malignant Hyperpyrexia Unit, 1971-84. Anaesthesia. 1986 Aug;41(8):809–815. doi: 10.1111/j.1365-2044.1986.tb13122.x. [DOI] [PubMed] [Google Scholar]
- Ellis F. R., Harriman D. G., Keaney N. P., Kyei-Mensah K., Tyrrell J. H. Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth. 1971 Jul;43(7):721–722. [PubMed] [Google Scholar]
- Fagerlund T., Islander G., Ranklev E., Harbitz I., Hauge J. G., Møkleby E., Berg K. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin Genet. 1992 May;41(5):270–272. [PubMed] [Google Scholar]
- Fletcher J. E., Rosenberg H., Michaux K., Tripolitis L., Lizzo F. H. Triglycerides, not phospholipids, are the source of elevated free fatty acids in muscle from patients susceptible to malignant hyperthermia. Eur J Anaesthesiol. 1989 Sep;6(5):355–362. [PubMed] [Google Scholar]
- Foster P. S., Gesini E., Claudianos C., Hopkinson K. C., Denborough M. A. Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine. Lancet. 1989 Jul 15;2(8655):124–127. doi: 10.1016/s0140-6736(89)90182-7. [DOI] [PubMed] [Google Scholar]
- Fujii J., Otsu K., Zorzato F., de Leon S., Khanna V. K., Weiler J. E., O'Brien P. J., MacLennan D. H. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 1991 Jul 26;253(5018):448–451. doi: 10.1126/science.1862346. [DOI] [PubMed] [Google Scholar]
- Gallant E. M., Mickelson J. R., Roggow B. D., Donaldson S. K., Louis C. F., Rempel W. E. Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia. Am J Physiol. 1989 Oct;257(4 Pt 1):C781–C786. doi: 10.1152/ajpcell.1989.257.4.C781. [DOI] [PubMed] [Google Scholar]
- Gillard E. F., Otsu K., Fujii J., Duff C., de Leon S., Khanna V. K., Britt B. A., Worton R. G., MacLennan D. H. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics. 1992 Aug;13(4):1247–1254. doi: 10.1016/0888-7543(92)90042-q. [DOI] [PubMed] [Google Scholar]
- Gillard E. F., Otsu K., Fujii J., Khanna V. K., de Leon S., Derdemezi J., Britt B. A., Duff C. L., Worton R. G., MacLennan D. H. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics. 1991 Nov;11(3):751–755. doi: 10.1016/0888-7543(91)90084-r. [DOI] [PubMed] [Google Scholar]
- Haan E. A., Freemantle C. J., McCure J. A., Friend K. L., Mulley J. C. Assignment of the gene for central core disease to chromosome 19. Hum Genet. 1990 Dec;86(2):187–190. doi: 10.1007/BF00197703. [DOI] [PubMed] [Google Scholar]
- Hall L. W., Woolf N., Bradley J. W., Jolly D. W. Unusual reaction to suxamethonium chloride. Br Med J. 1966 Nov 26;2(5525):1305–1305. doi: 10.1136/bmj.2.5525.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harbitz I., Chowdhary B., Thomsen P. D., Davies W., Kaufmann U., Kran S., Gustavsson I., Christensen K., Hauge J. G. Assignment of the porcine calcium release channel gene, a candidate for the malignant hyperthermia locus, to the 6p11----q21 segment of chromosome 6. Genomics. 1990 Oct;8(2):243–248. doi: 10.1016/0888-7543(90)90278-3. [DOI] [PubMed] [Google Scholar]
- Healy S. J., Heffron J. J., Lehane M., Bradley D. G., Johnson K., McCarthy T. V. Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers. BMJ. 1991 Nov 16;303(6812):1225–1228. doi: 10.1136/bmj.303.6812.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heiman-Patterson T., Martino C., Rosenberg H., Fletcher J., Tahmoush A. Malignant hyperthermia in myotonia congenita. Neurology. 1988 May;38(5):810–812. doi: 10.1212/wnl.38.5.810. [DOI] [PubMed] [Google Scholar]
- Holm C., Kirchgessner T. G., Svenson K. L., Fredrikson G., Nilsson S., Miller C. G., Shively J. E., Heinzmann C., Sparkes R. S., Mohandas T. Hormone-sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3. Science. 1988 Sep 16;241(4872):1503–1506. doi: 10.1126/science.3420405. [DOI] [PubMed] [Google Scholar]
- Imagawa T., Smith J. S., Coronado R., Campbell K. P. Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2+-permeable pore of the calcium release channel. J Biol Chem. 1987 Dec 5;262(34):16636–16643. [PubMed] [Google Scholar]
- Inui M., Saito A., Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem. 1987 Feb 5;262(4):1740–1747. [PubMed] [Google Scholar]
- Kalow W., Britt B. A., Terreau M. E., Haist C. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet. 1970 Oct 31;2(7679):895–898. doi: 10.1016/s0140-6736(70)92069-6. [DOI] [PubMed] [Google Scholar]
- Kim D. H., Sreter F. A., Ohnishi S. T., Ryan J. F., Roberts J., Allen P. D., Meszaros L. G., Antoniu B., Ikemoto N. Kinetic studies of Ca2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles. Biochim Biophys Acta. 1984 Sep 5;775(3):320–327. doi: 10.1016/0005-2736(84)90187-1. [DOI] [PubMed] [Google Scholar]
- Kolb M. E., Horne M. L., Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology. 1982 Apr;56(4):254–262. doi: 10.1097/00000542-198204000-00005. [DOI] [PubMed] [Google Scholar]
- Lai F. A., Erickson H. P., Rousseau E., Liu Q. Y., Meissner G. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature. 1988 Jan 28;331(6154):315–319. doi: 10.1038/331315a0. [DOI] [PubMed] [Google Scholar]
- Lai F. A., Erickson H., Block B. A., Meissner G. Evidence for a junctional feet-ryanodine receptor complex from sarcoplasmic reticulum. Biochem Biophys Res Commun. 1987 Mar 13;143(2):704–709. doi: 10.1016/0006-291x(87)91411-2. [DOI] [PubMed] [Google Scholar]
- Larach M. G., Landis J. R., Bunn J. S., Diaz M. Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry. Anesthesiology. 1992 Jan;76(1):16–27. doi: 10.1097/00000542-199201000-00003. [DOI] [PubMed] [Google Scholar]
- Levitt R. C., Nouri N., Jedlicka A. E., McKusick V. A., Marks A. R., Shutack J. G., Fletcher J. E., Rosenberg H., Meyers D. A. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics. 1991 Nov;11(3):543–547. doi: 10.1016/0888-7543(91)90061-i. [DOI] [PubMed] [Google Scholar]
- MacKenzie A. E., Korneluk R. G., Zorzato F., Fujii J., Phillips M., Iles D., Wieringa B., Leblond S., Bailly J., Willard H. F. The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy. Am J Hum Genet. 1990 Jun;46(6):1082–1089. [PMC free article] [PubMed] [Google Scholar]
- McCarthy T. V., Healy J. M., Heffron J. J., Lehane M., Deufel T., Lehmann-Horn F., Farrall M., Johnson K. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature. 1990 Feb 8;343(6258):562–564. doi: 10.1038/343562a0. [DOI] [PubMed] [Google Scholar]
- Mickelson J. R., Gallant E. M., Litterer L. A., Johnson K. M., Rempel W. E., Louis C. F. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem. 1988 Jul 5;263(19):9310–9315. [PubMed] [Google Scholar]
- Mickelson J. R., Gallant E. M., Rempel W. E., Johnson K. M., Litterer L. A., Jacobson B. A., Louis C. F. Effects of the halothane-sensitivity gene on sarcoplasmic reticulum function. Am J Physiol. 1989 Oct;257(4 Pt 1):C787–C794. doi: 10.1152/ajpcell.1989.257.4.C787. [DOI] [PubMed] [Google Scholar]
- Mickelson J. R., Ross J. A., Reed B. K., Louis C. F. Enhanced Ca2+-induced calcium release by isolated sarcoplasmic reticulum vesicles from malignant hyperthermia susceptible pig muscle. Biochim Biophys Acta. 1986 Nov 17;862(2):318–328. doi: 10.1016/0005-2736(86)90234-8. [DOI] [PubMed] [Google Scholar]
- Nelson T. E. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest. 1983 Sep;72(3):862–870. doi: 10.1172/JCI111057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Brien P. J. Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum. Can J Vet Res. 1986 Jul;50(3):318–328. [PMC free article] [PubMed] [Google Scholar]
- Powers P. A., Gregg R. G., Lalley P. A., Liao M., Hogan K. Assignment of the human gene for the alpha 1 subunit of the cardiac DHP-sensitive Ca2+ channel (CCHL1A1) to chromosome 12p12-pter. Genomics. 1991 Jul;10(3):835–839. doi: 10.1016/0888-7543(91)90471-p. [DOI] [PubMed] [Google Scholar]
- SAIDMAN L. J., HAVARD E. S., EGER E. I., 2nd HYPERTHERMIA DURING ANESTHESIA. JAMA. 1964 Dec 21;190:1029–1032. doi: 10.1001/jama.1964.03070250011002. [DOI] [PubMed] [Google Scholar]
- Snow J. C. Malignant hyperthermia during anesthesia and surgery. Arch Ophthalmol. 1970 Oct;84(4):407–408. doi: 10.1001/archopht.1970.00990040409001. [DOI] [PubMed] [Google Scholar]
- Zorzato F., Fujii J., Otsu K., Phillips M., Green N. M., Lai F. A., Meissner G., MacLennan D. H. Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem. 1990 Feb 5;265(4):2244–2256. [PubMed] [Google Scholar]